161 related articles for article (PubMed ID: 28239277)
1. Association of high mobility group BOX-1 and receptor for advanced glycation endproducts with clinicopathological features of haematological malignancies: a systematic review.
Nguyen AH; Bhavsar SB; Riley EM; Caponetti GC; Agrawal DK
Contemp Oncol (Pozn); 2016; 20(6):425-429. PubMed ID: 28239277
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
Nguyen AH; Detty SQ; Agrawal DK
Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
[TBL] [Abstract][Full Text] [Related]
3. Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review.
Nguyen A; Bhavsar S; Riley E; Caponetti G; Agrawal D
Int Arch Otorhinolaryngol; 2016 Oct; 20(4):382-389. PubMed ID: 27746844
[No Abstract] [Full Text] [Related]
4. Clinical use of high mobility group box 1 and the receptor for advanced glycation end products in the prognosis and risk stratification of heart failure: a literature review.
Marsh AM; Nguyen AH; Parker TM; Agrawal DK
Can J Physiol Pharmacol; 2017 Mar; 95(3):253-259. PubMed ID: 28092162
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma.
Li L; Beeraka NM; Xie L; Dong L; Liu J; Wang L
Discov Oncol; 2022 Jul; 13(1):64. PubMed ID: 35829833
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of RAGE and HMGB1 is associated with cancer progression and poor patient outcome of prostate cancer.
Zhao CB; Bao JM; Lu YJ; Zhao T; Zhou XH; Zheng DY; Zhao SC
Am J Cancer Res; 2014; 4(4):369-77. PubMed ID: 25057439
[TBL] [Abstract][Full Text] [Related]
7. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H
Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773
[TBL] [Abstract][Full Text] [Related]
8. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.
Ge X; Arriazu E; Magdaleno F; Antoine DJ; Dela Cruz R; Theise N; Nieto N
Hepatology; 2018 Dec; 68(6):2380-2404. PubMed ID: 29774570
[TBL] [Abstract][Full Text] [Related]
9. [Effect of high mobility group box protein 1 on the Kupffer cells of rats with severe burn and the role of receptor for advanced glycation end products in the process].
Sun L; Chen XL; Guo F; Wang F; Liu S; Liang X; Wang RS; Wang YJ; Sun YX
Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):158-61. PubMed ID: 23985205
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE).
Zhou H; Jin C; Cui L; Xing H; Liu J; Liao W; Liao H; Yu Y
J Cell Physiol; 2018 Sep; 233(9):6714-6721. PubMed ID: 29215715
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between the expression of high mobility group box 1 and receptor for advanced glycation end products and the onset of pre-eclampsia].
Gao L; Liu WH; Luan NN; Feng C; Shang T
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):746-50. PubMed ID: 19087540
[TBL] [Abstract][Full Text] [Related]
13. [Expression of high mobility group protein B1 in periodontal tissues and its association with hepatic lipid metabolism in diabetic rats with periodontitis].
Pei X; Meng S; Gou C; Du Q
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):6-12. PubMed ID: 32376562
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
15. Ectodomain Shedding of RAGE and TLR4 as a Negative Feedback Regulation in High-Mobility Group Box 1-Activated Aortic Endothelial Cells.
Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
Cell Physiol Biochem; 2018; 51(4):1632-1644. PubMed ID: 30497069
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products.
Sparatore B; Pedrazzi M; Passalacqua M; Gaggero D; Patrone M; Pontremoli S; Melloni E
Biochem J; 2002 May; 363(Pt 3):529-35. PubMed ID: 11964153
[TBL] [Abstract][Full Text] [Related]
17. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
18. High mobility group protein B1 (HMGB1) interacts with receptor for advanced glycation end products (RAGE) to promote airway smooth muscle cell proliferation through ERK and NF-
Qu D; Ling Z; Tan X; Chen Y; Huang Q; Li M; Liu T; Hou C; Chen Y
Int J Clin Exp Pathol; 2019; 12(9):3268-3278. PubMed ID: 31934170
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
20. Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps.
Dzaman K; Szczepanski MJ; Molinska-Glura M; Krzeski A; Zagor M
Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):223-30. PubMed ID: 25503556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
